Hepion Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Hepion Pharmaceuticals Stock Summary

Hepion Pharmaceuticals competes with Enveric Biosciences, Elevation Oncology, Ocean Biomedical, and Zura Bio. Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey. Hepion Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 20 people.

Hepion Pharmaceuticals Key Financial Ratios

Hepion Pharmaceuticals Key Balance Sheet Accounts

Hepion Pharmaceuticals Key Income Statement Accounts

Hepion Pharmaceuticals Key Cash Accounts

Hepion Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Hepion Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Hepion Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hepion Pharmaceuticals competition to find correlations between indicators driving Hepion Pharmaceuticals's intrinsic value. More Info.Hepion Pharmaceuticals is rated # 5 in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Hepion Pharmaceuticals' Return On Equity is projected to drop slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hepion Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Hepion Pharmaceuticals Systematic Risk

Today, most investors in Hepion Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Hepion Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Hepion Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Hepion Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Hepion Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Hepion Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Hepion Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Hepion Pharmaceuticals's daily price indicators and compare them against related drivers.

When running Hepion Pharmaceuticals' price analysis, check to measure Hepion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hepion Pharmaceuticals is operating at the current time. Most of Hepion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hepion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hepion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hepion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.